An Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in Branchburg, NJ., in this file photo. Mike Segar/Reuters
Pharmaceutical giant Eli Lilly is warning patients about the potential danger of taking compounded tirzepatide, marketed as Zebound and Mounjaro, mixed with vitamin B12.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/business/eli-lilly-warns-of-safety-risk-from-compounded-zepbound-drugs-mixed-with-vitamin-b12-5997836/?utm_source=partner&utm_campaign=whatfinger
